— Know what they know.
Not Investment Advice

068760.KS KSC

Celltrion Pharm Inc
1W: -3.6% 1M: -19.4% 3M: -6.4% 1Y: +0.5% 3Y: -7.5% 5Y: +0.4%
₩93,500.00
Last traded 2024-08-14 — delisted
KSC · Healthcare · Drug Manufacturers - Specialty & Generic
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩0.0M ($0.0M)
52W Range49600.0-119800.0
Volume0
Avg Volume222,553
Beta-0.02
Dividend—
Analyst Ratings
No analyst coverage
About Celltrion Pharm Inc

Celltrion Pharm Inc. operates within South Korea's healthcare industry, primarily focusing on the production and distribution of a diverse range of pharmaceutical products. These include heptatonics, pain relievers, fever reducers, anti-inflammatory medications, allergy treatments, medications for respiratory ailments, and antibacterial agents.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms